A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)

NCT03859869 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Business Considerations (difficulty with enrollment)

Conditions

Exocrine Pancreatic Insufficiency (EPI)

Interventions

DRUG: Pancrelipase
DRUG: Placebo

Sponsor

AbbVie